Monthly Archives: June 2018

(CNBC) Greece is due to exit its latest bailout programme in August and will then have to rely on financial markets to cover its borrowing needs.The nation has a debt-to-GDP ratio of 179.8 percent — the highest in the 19-nation […]

(CNBC) M&A bankers including Goldman Sachs stand to share $180 million in advisory fees, according to Freeman Consulting.The bigger haul comes from financing Comcast’s $65 billion all-cash offer, which could result in $300 million in fees.Investment bankers were already on […]

(Harvest) Applied Equity Advisors combines factor investing with stock-specific research. Tapping both sources of excess returns helps us achieve greater consistency of returns and avoid behavioral pitfalls. To read this article:

(Hedgeweek) Virtual data room provider Intralinks has released the initial results of its 2018 LP Survey which, among other things, found that nearly two-thirds of the limited partners (LPs) queried expect to increase their allocations to alternative investments in 2018. […]

(Bloomberg) The World Cup kicks off today, minutes after this newsletter publishes, which means that there will be no finance news for the next month. That will make this newsletter a bit of a slog, sorry. So I guess let’s […]

(Bloomberg) The media industry is in a frenzy. AT&T is buying Time Warner for $85 billion after overcoming a challenge from the Justice Department. The Murdoch family has agreed to sell the majority of its 21st Century Fox empire to […]

(Bloomberg) Ever wonder why hedge fund managers are so willing to get up on a stage and tell the world about their best ideas? A new study suggests an answer: the ideas are getting old, and they need a spot […]

(Reuters) William Ackman’s private hedge fund has gained more than 9 percent this year while his publicly traded fund is up double digits, marking a dramatic reversal for the billionaire investor after three years of losses. To read this article:

(Reuters) Allergan Plc (AGN.N) said on Thursday former Abbott Laboratories (ABT.N) executive Thomas Freyman will join its board, a week after two of its shareholders criticized the drugmaker’s acquisition strategy and board composition. To read this article:

(Reuters) Investors continue to reduce their bullish position in crude oil futures and options, after a blistering rally over the last year, but now the profit-taking has spread to refined fuels such as gasoline and heating oil. Hedge funds and […]

(Reuters) Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management’s nominees. Glass Lewis & Co’s recommendation, released to clients late on Tuesday […]